Carcinoma, Hepatocellular: all 3,249 studies
Page 25 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular CarcinomaCompletedNCT02981498Phase 2
- HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.CompletedNCT02973685Phase 3
- Circulating Tumor Cells and Tumor DNA in HCC and NETCompletedNCT02973204
- Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients.CompletedNCT02971696Phase 3
- Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor ThrombusStatus unknownNCT02971345Phase 3
- Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic CarcinomaStatus unknownNCT02969096Phase 2
- Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCCStatus unknownNCT02967887Phase 2
- Liver Function Investigation With SPECTActive, not recruitingNCT02967848
- Surefire Precision Infusion System RegistryTerminatedNCT02967523
- RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular CarcinomaStatus unknownNCT02964260Not applicable
- Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical TrailCompletedNCT02961998Phase 4
- DAA in the Risk of Recurrence After Curative Treatment of HCCWithdrawnNCT02959359Phase 4
- A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver MalignancyStatus unknownNCT02959151Phase 1/2
- Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)TerminatedNCT02958163Phase 2
- Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) PatientsStatus unknownNCT02956772Phase 2
- Pharmacokinetic Study of E7080/Lenvatinib in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC)CompletedNCT02953743Phase 1
- Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.CompletedNCT02947165Phase 1
- Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular CarcinomaWithdrawnNCT02946138Phase 2
- Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric CancerStatus unknownNCT02942329Phase 1/2
- Factors Influencing the 3-Year Recurrence of Liver Carcinoma After SurgeryCompletedNCT02941861
- A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT02939807Phase 2
- Hepatic Arteriography in Liver Cancer Diagnosis and Staging ApplicationsStatus unknownNCT02936856Not applicable
- Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver TransplantationSuspendedNCT02935478Not applicable
- Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular CancerCompletedNCT02929082Not applicable
- Clinical Significance of Hepatic and Circulating microRNAs miR-221 and miR-222 in Hepatocellular CarcinomaTerminatedNCT02928627
- Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular CarcinomaCompletedNCT02927626Early Phase 1
- Comparing Re-TACE Versus SABR for Post-prior-TACE Incompletely Regressed HCC: a Randomized Controlled Trial (TASABR)Status unknownNCT02921139Not applicable
- Liver and Biliary Tumor Tissue RegistryTerminatedNCT02917759
- Randomized Phase II Trial of Chemoembolization and SorafenibWithdrawnNCT02908165Phase 2
- Extracellular RNA Markers of Liver Disease and CancerTerminatedNCT02908048
- Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)CompletedNCT02906397Phase 1
- Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)CompletedNCT02905188Phase 1
- FDGal PET/CT to Detect Hepatocellular CarcinomaWithdrawnNCT02899325
- Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC)CompletedNCT02898415
- Hepatocellular Carcinoma and Rheumatoid ArthritisCompletedNCT02880306
- DCE-MRI for Assessment of Response to TACE of HCCCompletedNCT02878109
- Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization MicrospheresCompletedNCT02870010Phase 1
- Myeloid Derived Suppressor Cells Control by Signal Regulatory Protein-alpha: Investigation in Hepatocellular CarcinomaCompletedNCT02868255
- Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical ResectionTerminatedNCT02867280Phase 3
- Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency AblationCompletedNCT02859753Not applicable
- Safety and Efficacy of "Immuncell-LC" in TACE TherapyCompletedNCT02856815Phase 2
- HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCCCompletedNCT02856126Phase 3
- A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular CarcinomaCompletedNCT02854839Phase 2
- Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 RadioembolizationCompletedNCT02848638
- Dynamic Contrast Enhanced HCC SABR Liver StudyStatus unknownNCT02847767Not applicable
- Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With SorafenibTerminatedNCT02847468Not applicable
- Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular CarcinomaCompletedNCT02834546
- Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) ScreeningCompletedNCT02833298Not applicable
- RFA for Small HCC With No-touch Technique Using Octopus ElectrodeCompletedNCT02832882Not applicable
- No-touch RFA Versus Traditional RFA for Small Hepatocellular CarcinomaStatus unknownNCT02830737Not applicable
- A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver CancersCompletedNCT02828865Not applicable
- Combined Fluorocholine Positron Emission Tomography and Magnetic Resonance Imaging (FCH-PET/MRI) in Curative Treatment of a Hepatocellular CarcinomaCompletedNCT02824185Not applicable
- Chemoembolization for Hepatocellular CarcinomaTerminatedNCT02821533Phase 2
- The Combination Effect of Statin Plus Metformin on Relapse-freeTerminatedNCT02819869Phase 2
- Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control TrialStatus unknownNCT02817685
- The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCCCompletedNCT02814461Phase 1
- Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT PatientsStatus unknownNCT02813096Not applicable
- A Study of Anlotinib in Patients With Hepatocellular CarcinomaStatus unknownNCT02809534Phase 2
- A Novel Laparoscopic Hepatectomy Posture, Left Lateral Position Plus Jackknife PositionCompletedNCT02809287
- RFA for Small HCC With No-touch Technique and Dual Cooled-Wet ElectrodeStatus unknownNCT02806076Not applicable
- Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular CarcinomaTerminatedNCT02802124Not applicable
- Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular CarcinomaCompletedNCT02799212Phase 3
- Determination of HCC With Octanoate Breath Test vs. MRI DiagnosisCompletedNCT02794805Phase 2
- TACE vs TACE+SBRT for Unresectable Hepatocellular CancerStatus unknownNCT02794337Phase 2/3
- Adjuvant TACE to Reduce the HCC Recurrence After ResectionCompletedNCT02788526Phase 3
- Prospective Tumor Response EvaluationTerminatedNCT02787954
- Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With SorafenibStatus unknownNCT02786342
- Hepatocellular Carcinoma in HIV-infected PatientsCompletedNCT02785835
- Prospective Post Y90 Liver HypertrophyStatus unknownNCT02783261
- Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCCCompletedNCT02774187Phase 3
- B-mode Ultrasound Imaging in Detecting Early Liver CancerCompletedNCT02774161Not applicable
- A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment FailureStatus unknownNCT02772029Phase 1/2
- DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus InfectionActive, not recruitingNCT02772003Phase 1
- Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCCCompletedNCT02771405Phase 3
- Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After ResectionStatus unknownNCT02767375Phase 2/3
- Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue SamplesCompletedNCT02762721
- Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)Status unknownNCT02759601Phase 1/2
- Radiomics of Hepatocellular CarcinomaStatus unknownNCT02757846
- Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular CarcinomaStatus unknownNCT02755311Phase 3
- Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular CarcinomaTerminatedNCT02748304Not applicable
- DEB-TACE for Hepatocellular CarcinomaTerminatedNCT02748161Not applicable
- Clinical Intervention Modelling, Planning and Proof for Ablation Cancer TreatmentStatus unknownNCT02745600Not applicable
- Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies: Follow-up StudyCompletedNCT02745483Phase 2
- HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in ChinaStatus unknownNCT02743065
- Adjuvant Chemotherapy With FOLFOX in HCC Patients After ResectionStatus unknownNCT02738697Phase 3
- Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT02733809Phase 4
- Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and CholangiocarcinomaCompletedNCT02730611
- Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular CarcinomaStatus unknownNCT02729506Phase 4
- Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP ConversionCompletedNCT02728219Not applicable
- Standard Treatments of Very-early Stage Hepatocellular CarcinomaCompletedNCT02728193Not applicable
- A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma PatientsStatus unknownNCT02727309Phase 1/2
- By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative TherapyStatus unknownNCT02725996Phase 2
- Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor ThrombusCompletedNCT02724475Not applicable
- Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular CarcinomaCompletedNCT02724436Not applicable
- Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1CompletedNCT02724358Not applicable
- Postoperative Adjuvant TACE Treatment in CK18 Positive PatientsCompletedNCT02724345
- Targeted Internal Radiation Therapy in Advanced HCC Patients.CompletedNCT02724267Not applicable
- CAR-T Cell Immunotherapy for HCC Targeting GPC3WithdrawnNCT02723942Phase 1/2
- A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver TransplantationStatus unknownNCT02719782Phase 1
- Prospective, Multicenter HCCIS Evaluation StudyStatus unknownNCT02718235